Welcome to the Growery Message Board! You are experiencing a small sample of what the site has to offer. Please login or register to post messages and view our exclusive members-only content. You'll gain access to additional forums, file attachments, board customizations, encrypted private messages, and much more!
|
 x7x_x7x
cultivando en la miseria
Registered: 11/25/10
Posts: 32
Last seen: 1 year, 1 month
|
 Argentina: The Anmat 85 treatments authorized medical marijuana  1
#817774 - 08/05/16 06:19 PM (8 years, 3 months ago) |
|
|
This was announced yesterday its owner before the Health Committee of the Chamber of Deputies; were requests for compassionate use
So far this year, the country requests 85 patients were authorized to import a product derived from marijuana for compassionate use. It is an oil with cannabidiol, which is the main component of the marijuana plant and is produced in the United States.
Yesterday, the head of the National Administration of Food, Drug and Technology (ANMAT) informed the Health Commission of the Chamber of Deputies that the agency had authorized the entry of 85 bottles of the product in the last five months. According could know the NATION, it treated 80 applications for the treatment of symptoms of refractory epilepsy and five requests to relieve pain. This form of epilepsy is resistant to antiepileptic available.
The "compassionate use" is a resource that allows to buy abroad and import drugs into the country without tariffs that do not occur or are not available in our country. For that, a medical indication and evidence that the patient does not respond to existing therapies, among other requirements on the usefulness of the product to be imported and their active ingredients are needed. The application is filed in the office of Foreign Trade Service located in the building of the National Institute of Medicines (Iname), which depends on the Anmat.
"We are totally in favor of allowing the import of these treatments (cannabis)," said Carlos Chiale, national manager Anmat during the meeting in the annex building of the National Congress. "It is not the panacea or placebo he continued. You have to know to handle. In the best case, it is a recommended adjuvant treatment that improves quality of life. And that is not less."
Chiale said that given the country's installed laboratories public drug production, "what better than as a strategic production are developed in these laboratories such products' capability.
Last March, the Anmat issued a document on substances subject to special control: psychotropics, narcotics, chemical precursors and substances cutting. "Given that the country no drugs derived from cannabis are produced, access is only by an import intended to address the treatment of a particular patient, resulting in an access of emergency (compassionate use)," says the document. The agency anticipated, then he was doing "a rigorous assessment of the international scientific evidence" on products derived substances, whether natural or synthetic cannabis.
Yesterday, Chiale handed to the Health Committee, chaired by Rep Carolina Gaillard (FPV), a copy of the results obtained after analyzing 16 systematic reviews and meta-analyzes and two observational studies on the efficacy and safety of cannabinoids in patients any age to treat chronic pain, nausea and vomiting from chemotherapy; stimulation of appetite in people living with HIV / AIDS; spasticity in multiple sclerosis; Tourette syndrome and refractory epilepsy.
For now, the available studies do not allow a conclusion on the treatment to reduce tics of Tourette syndrome. Instead, on pain, it was observed that "cannabinoids show slight to moderate benefits" compared with placebo, and "smoked THC proved to be the most effective intervention."
As for refractory epilepsy, "the work done with cannabidiol found in 40% of the study population, all cases with severe epileptic encephalopathies, a reduction in seizure frequency of more than 50% and adverse effects on 12% the population. these results are similar to the latest drugs available for these forms of epilepsy, "said Silvia Kochen, director of the Center for Clinical Neurosciences and Applied, epilepsy, Cognition and Conduct of the Institute of Cell Biology and Neurosciences of the Faculty of Medicine UBA-CONICET. So Kochen considered during its presentation to the commission "to legalize their use and conduct controlled as with other molecules studies."
For spasticity and spasms with pain in multiple sclerosis, the evidence indicates that the nabiximols, according to the Anmat could have a "significant" role with standard therapies. And cannabinoids were shown to be more effective than placebo in reducing nausea and vomiting after chemotherapy four times. In patients with HIV / AIDS, megestrol acetate was superior to cannabinoids.
With yesterday's meeting began treating the bills to decriminalize marijuana for use in health. There are five initiatives presented on the subject. They are of Deputies Hector Gutierrez (UCR), Victoria Donda (Libres del Sur), Soledad Sosa Capurro (Left Front), Diana Conti and Araceli Ferreyra, both FPV.
http://www.lanacion.com.ar/1909033-la-anmat-autorizo-85-tratamientos-con-marihuana-de-uso-medicinal
| |
|
|
You cannot start new topics / You cannot reply to topics
HTML is disabled / BBCode is enabled
Moderator: geokills
1,820 topic views. 0 members, 55 guests and 35 web crawlers are browsing this forum.
[ Show Images Only | Sort by Score | Print Topic ] | | |
|
|
|
Threaded
Previous
Index
Next
Edit 
Reply 
